Immune impairment thresholds in HIV infection

Immunology Letters

Volumn 123, Issue 2, 2009, Pages 149-154

  Iwami, Shingo ^a   Nakaoka, Shinji ^b,c   Takeuchi, Yasuhiro ^a   Miura, Yoshiharu ^d,e   Miura, Tomoyuki ^d  

^a SHIZUOKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e Saitama Prefectural Rehabilitation Center   (Japan)

Author keywords

Dendritic cell; Distribution of asymptomatic period; HIV infection; Immune impairment; Immunodeficiency; Mathematical model

Indexed keywords

ARTICLE; CELL COUNT; CELL FUNCTION; DENDRITIC CELL; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MATHEMATICAL MODEL; PRIORITY JOURNAL; SURVIVAL RATE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DENDRITIC CELLS; DISEASE PROGRESSION; HIV; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 67349222264     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.03.007     Document Type: Article

References (49)

1. Altes H.K., Wodarz D., and Jansen V.A.A. The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination. J Theor Biol 214 (2002) 633-646
2. Binley J.M., Clas B., Gettie A., Vesanen M., Montefiori D.C., and Sawyer L. Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia. Virology 270 (2000) 237-249
3. CASCADE Collaboration. Time from HIV-1 seroconversion to AIDS and death before widespread use of highlyactive antiretroviral therapy: a collaborative re-analysis. Lancet 2000; 355:1131-7.
4. Cecilia D., Kleeberger C., Munoz A., Giorgi J.V., and Zolla-Pazner S. A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects. J Infect Dis 179 (1999) 1365-1374
5. Ciupe M.S., Bivort B.L., Bortz D.M., and Nelson P.W. Estimating kinetic parameters from HIV primary infection data through the eyes of three different mathematical models. Math Biosci 200 (2006) 1-27
6. Connolly N.C., Whiteside T.L., Wilson C., Kondragunta V., Rinaldo C.R., and Riddler S.A. Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals. Clin Vaccine Immunol 15 (2008) 284-292
7. Davenport M.P., Ribeiro R.M., and Perelson A.S. Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection. J Virol 78 (2004) 10096-10103
8. Donaghy H., Pozniak A., Gazzard B., Qazi N., Gilmour J., and Gotch F. Loss of blood CD11c+ myeloid and CD11c- plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98 (2001) 2574-2576
9. Donaghy H., Gazzard B., Gotch F., and Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 101 (2003) 4505-4511
10. de Boer R.J., and Boerlijst M.C. Diversity and virulence thresholds in AIDS. Proc Natl Acad Sci USA 94 (1994) 544-548
11. Galvani A.P. The role of mutation accumulation in HIV progression. Proc Roy Soc Lond B 272 (2005) 1851-1858
12. Garcia F., Lejeune M., Climent N., Gil C., Alcami J., and Morente V. Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection. J Infect Dis 191 (2005) 1680-1685
13. Gayet-Ageron A., Baratin D., Marceillac E., Allard R., Peyramond D., and Chidiac C. The AIDS epidemic in Lyon: patient characteristics and defining illnesses between 1985 and 2000. HIV Med 5 (2004) 163-170
14. Hogue I.B., Bajaria S.H., Fallert B.A., Qin S., Reinhart T.A., and Kirschner D.E. The dual role of dendritic cells in the immune response to human immunodeficiency virus type 1 infection. J Gen Virol 89 (2008) 2228-2239
15. Iwami S., Nakaoka S., and Takeuchi Y. Viral diversity limits immune diversity in asymptomatic phase of HIV infection. Theor Pop Biol 73 (2008) 332-341
16. Iwami S, Miura T, Nakaoka S, Takeuchi Y. Immune impairment effect in HIV infection: existence of risky and immunodeficiency thresholds. J Theor Biol, in press.
17. Iwasa Y., Michor F., and Nowak M.A. Virus evolution within patients increases pathogenicity. J Theor Biol 232 (2005) 17-26
18. Janewa C, Travers P, Walport M, Shlomchik MJ. Immunobiology: the immune system in health and disease. Garland Pub.; 2004.
19. Kamp C., and Bornholdt S. From HIV infection to AIDS: a dynamically induced percolation transition?. Proc Roy Soc Lond B 269 (2002) 2035-2040
20. Kawamura T., Gatanaga H., Borris D.L., Connors M., Mitsuya H., and Blauvelt A. Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells. J Immunol 170 (2003) 4260-4266
21. Kozyrev I.L., Ibuki K., Shimada T., Kuwata T., Takemura T., and Hayami M. Characterization of less pathogenic infectious molecular clones derived from acute-pathogenic SHIV-89.6P stock virus. Virology 282 (2001) 6-13
22. Lore K., Sonnerborga A., Brostrom C., Goh L.-E., Perrin L., and McDade H. Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 16 (2002) 683-692
23. Macatonia S.E., Lau R., Patterson S., Pinching A.J., and Knight S.C. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71 (1990) 38-45
24. Mandl J.N., Regoes R.R., Garber D.A., and Feinberg M.B. Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape. J Virol 81 (2007) 11982-11991
25. McKnight A., and Clapham P.R. Immune escape and tropism of HIV. Tre Micro 3 (1995) 356-361
26. McMichael A.J., and Rowland-Jones S.L. Cellular immune responses to HIV. Nature 410 (2001) 980-987
27. Meissnera E.G., Duus K.M., Gao F., Yu X.-F., and Su L. Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope. Virology 328 (2004) 74-88
28. Mellors J.W. Viral-load tests provide valuable answers. Sci Am (1998) July:70
29. Nowak M.A., and May R.M. Virus dynamics (2000), Oxford University Press
30. Nowak M.A. Evolutionary dynamics (2006), Harvard University Press
31. Nowak M.A., Anderson R.M., McLean A.R., Wolfs T.F., Goudsmit J., and May R.M. Antigen diversity thresholds and the development of AIDS. Science 15 (1991) 963-969
32. Nowak M.A. Variability in HIV infections. J Theor Biol 155 (1992) 1-20
33. Nowak M.A., and May R.M. AIDS pathogenesis: mathematical models of HIV and SIV infection. AIDS 7 (1993) S3-S18
34. Ogg G.S., Jin X., Bonhoeffer S., Moss P., Nowak M.A., and Monard S. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol 73 (1999) 797-800
35. Patterson S., English N.R., Longhurst H., Balfe P., Helbert M., and Pinching A.J. Analysis of human immunodeficiency virus type 1 (HIV-1) variants and levels of infection in dendritic and T cells from symptomatic HIV-1-infected patients. J Gen Virol 79 (1998) 247-257
36. Regoes R.R., Wodarz D., and Nowak M.A. Virus dynamics: the effect of target cell limitation and immune responses on virus evolution. J Theor Biol 191 (1998) 451-462
37. Regoes R.R., and Bonhoeffer S. The HIV coreceptor switch: a population dynamical perspective. Tre Micro 13 (2005) 269-277
38. Richman D.D. HIV chemotherapy. Nature 410 (2001) 995-1001
39. Rinaldo C.R. Dendritic cell-based human immunodeficiency virus vaccine. J Int Med 265 (2008) 138-158
40. Sartwell P. The incubation period and the dynamics of infectious disease. Am J Epidemiol 83 (1966) 204-216
41. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., and Lifton M.A. Control of viremia in simian immunodeficiency virus infection by CD8(+) lymphocytes. Science 283 (1999) 857-860
42. Smed-Sorensen A., Lore K., Walther-Jallow L., Anderson J., and Spetz A. HIV-1 infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 104 (2004) 2810-2817
43. Soumelis V., Scott I., Gheyas F., Bouhour D., Cozon G., and Cotte L. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98 (2001) 906-912
44. Stafford M.A., Corey L., Cao Y., Daar E.S., Ho D.D., and Perelson A.S. Modeling plasma virus concentration during primary HIV infection. J Theor Biol 203 (2000) 285-301
45. Tassie J.-M., Grabar S., Lancar R., Deloumeaux J., Bentata M., and Costagliola D. Time to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection. J AIDS 30 (2002) 81-87
46. Thieme H.R. Mathematics in population biology (2003), Princeton University Press
47. Wodarz D., Klenerman P., and Nowak M.A. Dynamics of cytotoxic T-lymphocyte exhaustion. Proc Roy Soc Lond B 265 (1998) 191-203
48. Wu L., and KewalRamani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 6 (2006) 859-868
49. Tunetsugu-Yokota Y. How does HIV infection destory the host immune system?. J AIDS Res 7 (2005) 171-179